Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
FATEFate Therapeutics	$260.01m	n/a	n/a
INZYInozyme Pharma	$257.60m	n/a	n/a
OCGNOcugen	$252.37m	n/a	n/a
ELTXElicio Therapeutics	$251.82m	n/a	n/a
LXEOLexeo Therapeutics	$251.20m	n/a	n/a
EVMNEvommune	$247.08m	n/a	n/a
ELDNEledon Pharmaceuticals	$247.03m	n/a	n/a
VNDAVanda Pharmaceuticals	$244.87m	n/a	n/a
CAMPCAMP4 Therapeutics	$244.74m	n/a	n/a
THRDThird Harmonic Bio	$242.79m	n/a	n/a
TLSITriSalus Life Sciences	$237.68m	n/a	n/a
IKTInhibikase Therapeutics	$233.02m	n/a	n/a
SLRNAcelyrin	$227.15m	n/a	n/a
PYXSPyxis Oncology	$226.01m	n/a	n/a
KROSKeros Therapeutics	$225.24m	n/a	n/a
SLGLSOL-GEL TECHNOLOGIES	$224.79m	n/a	n/a
MACKMerrimack Pharmaceuticals	$223.75m	n/a	n/a
CRGXCARGO Therapeutics	$219.57m	n/a	n/a
BBOTBridgebio Oncology Therapeutics	$216.47m	n/a	n/a
SPPISpectrum Pharmaceuticals	$211.40m	n/a	n/a